Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association’s Annual Meeting

Research To Practice | Oncology Videos

Featuring perspectives from Drs Arjun Balar, Ashish Kamat, Guru Sonpavde and Robert Svatek, including the following topics:

• Personalized Continuing Medical Education
  • Introduction (0:00)
  • Understanding the Millennial Physician — Jason Hafron, MD (2:30)
• Non-Muscle-Invasive Urothelial Bladder Cancer (UBC)
  • Case: A man in his late 70s with bacillus Calmette-Guérin (BCG)-refractory non-muscle-invasive bladder cancer — David S Morris, MD (9:27)
  • Case: A man in his mid-60s with high-risk non-muscle-invasive UBC — Gordon A Brown, DO (14:45)
  • Case: A man in his late 50s with high-risk, BCG-refractory non-muscle-invasive bladder cancer — Dr Hafron (23:03)
  • Case: A man in his mid-80s with recurrent high-grade noninvasive papillary carcinoma — Dr Morris (32:16)
• Neoadjuvant and Adjuvant Treatment of Muscle-Invasive UBC
  • Case: A man in his mid-80s with muscle-invasive bladder cancer who declines cystectomy — Sulfi Ibrahim, MD (37:22)
  • Selection of Patients for Neoadjuvant Therapy — Dr Morris (44:08)
  • Case: A man in his late 70s with Gleason 4 + 3 adenocarcinoma of the prostate and urothelial carcinoma — Dr Hafron (53:03)
• Treatment of Metastatic UBC
  • Urologists’ Questions about Second- and Later-Line Therapies and Management of Side Effects — Dr Morris (1:02:11)
  • Case: A woman in her early 70s with metastatic UBC, PD-L1 30% — Dr Ibrahim (1:09:15)
  • Case: A woman in her mid-50s with muscle-invasive bladder cancer — Dr Brown (1:25:20)

CME information and select publications